Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of computations of basic and diluted loss per share

The following table presents computations of basic and diluted earnings per share for Holdings:


	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2025			2024			2025			2024
Numerator:
Net income attributable to Cinemark Holdings, Inc.	$	49.5		$	187.8		$	104.1		$	258.4
Income allocated to participating share-based awards (1)		(0.6	)		(3.6	)		(1.3	)		(5.0	)
Basic net income attributable to common stockholders	$	48.9		$	184.2		$	102.8		$	253.4
Add: Interest expense on convertible notes, net of tax		—			3.9			4.6			12.3
Add: Loss on warrants (2)		—			—			—			—
Diluted net income attributable to common stockholders	$	48.9		$	188.1		$	107.4		$	265.7

Denominator:
Basic weighted average shares outstanding		113.8			120.0			115.5			119.8
Common equivalent shares for performance stock units		2.1			2.0			2.2			1.9
Common equivalent shares for restricted stock units		0.1			—			0.1			—
Common equivalent shares for convertible notes (3)		7.8			32.0			21.6			32.0
Common equivalent shares for warrants (2),(4)		—			4.2			—			—
Diluted weighted average shares outstanding		123.8			158.2			139.4			153.7

Basic earnings per share attributable to common stockholders	$	0.43		$	1.54		$	0.88		$	2.11
Diluted earnings per share attributable to common stockholders	$	0.40		$	1.19		$	0.77		$	1.73

(1)

For the three months ended September 30, 2025 and 2024, a weighted average of approximately 1.50 shares and 2.38 shares of restricted stock, respectively, were considered participating securities. For the nine months ended September 30, 2025 and 2024, a weighted average of approximately 1.37 shares and 2.38 shares of restricted stock, respectively, were considered participating securities.

(2)

For the three and nine months ended September 30, 2025, diluted earnings per share excludes the warrants, as they would be anti-dilutive when adjusting the basic net income attributable to common shareholders for the loss on warrants recorded during each respective period.

(3)

For the three and nine months ended September 30, 2024, the diluted earnings per share excludes the convertible note hedge transactions, as they would be anti-dilutive. See Convertible notes, hedges and warrants below for discussion of the convertible note hedge transactions as they relate to basic and diluted earnings per share for the three and nine months ended September 30, 2025.

(4)

For the nine months ended September 30, 2024, diluted earnings per share excludes the warrants, as they would be anti-dilutive since the strike price exceeded the average price of Holdings’ common stock during the relevant period.